SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

73,246.03 -352.64
( -0.48%)

Global Indices

Nasdaq

52,406.83 24.25
(0.05%)

Dow Jones

7,744.04 46.27
(0.60%)

Hang Seng

64,060.29 791.92
(1.25%)

Nikkei 225

10,683.77 -2.77
(-0.03%)

Forex

USD-INR

95.11 0.17
(0.18%)

EUR-INR

106.49 0.13
(0.12%)

GBP-INR

127.03 0.10
(0.08%)

JPY-INR

0.60 0.00
(-0.05%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Medicamen Organics Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

92885

INE0PE401018

25.7426784

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

MEDIORG

37.57

EPS(TTM)

Face Value()

Div & Yield %

Back

&hra cements ltd

Wanbury update on filing of DFM in US and South Korea

Jul 30,2026

Wanbury recently received “No DMF deficiency letter” from the office of USFDA (US Food and Drug Administration) for multiple ANDAs (Abbreviated New Drug Applications) with Metformin HCl API source of Wanbury for different formulations.

Further, Wanbury expanded business opportunities in South Korea for one more API by filing the DMF. Wanbury is committed for supply of best APIs to the new market for well-being of human being.

73,246.03 -352.64 ( -0.48%)

52,406.83 24.25 (0.05%)

7,744.04 46.27 (0.60%)

64,060.29 791.92 (1.25%)

10,683.77 -2.77 (-0.03%)

95.11 0.17 (0.18%)

106.49 0.13 (0.12%)

127.03 0.10 (0.08%)

0.60 0.00 (-0.05%)